ES3063485T3 - Compositions and methods of using itaconic acid derivatives - Google Patents

Compositions and methods of using itaconic acid derivatives

Info

Publication number
ES3063485T3
ES3063485T3 ES19826034T ES19826034T ES3063485T3 ES 3063485 T3 ES3063485 T3 ES 3063485T3 ES 19826034 T ES19826034 T ES 19826034T ES 19826034 T ES19826034 T ES 19826034T ES 3063485 T3 ES3063485 T3 ES 3063485T3
Authority
ES
Spain
Prior art keywords
compositions
methods
acid derivatives
itaconic acid
itaconic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19826034T
Other languages
English (en)
Spanish (es)
Inventor
Adonia Papathanassiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ergon Pharmaceuticals LLC
Original Assignee
Ergon Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ergon Pharmaceuticals LLC filed Critical Ergon Pharmaceuticals LLC
Application granted granted Critical
Publication of ES3063485T3 publication Critical patent/ES3063485T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/44Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES19826034T 2018-06-29 2019-07-01 Compositions and methods of using itaconic acid derivatives Active ES3063485T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862763735P 2018-06-29 2018-06-29
PCT/US2019/040121 WO2020006557A1 (en) 2018-06-29 2019-07-01 Compositions and methods of using itaconic acid derivatives

Publications (1)

Publication Number Publication Date
ES3063485T3 true ES3063485T3 (en) 2026-04-16

Family

ID=68985877

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19826034T Active ES3063485T3 (en) 2018-06-29 2019-07-01 Compositions and methods of using itaconic acid derivatives

Country Status (5)

Country Link
US (1) US12060310B2 (https=)
EP (1) EP3813815B1 (https=)
JP (1) JP7396682B2 (https=)
ES (1) ES3063485T3 (https=)
WO (1) WO2020006557A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55795A (fr) 2019-04-30 2022-03-09 Sitryx Therapeutics Ltd Dérivés d'acide itaconique et leurs utilisations dans le traitement d'une maladie inflammatoire ou d'une maladie associée à une réponse immunitaire indésirable
EP4237404A1 (en) * 2020-10-29 2023-09-06 Sitryx Therapeutics Limited Novel compounds
EP4326247A1 (en) 2021-04-23 2024-02-28 Helmholtz-Zentrum für Infektionsforschung GmbH Citraconic acid and derivatives thereof for use as a medicament
CN119685257B (zh) * 2024-12-16 2026-02-27 华中科技大学同济医学院附属协和医院 体外诱导t细胞免疫记忆分化的方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260479A (en) * 1991-12-16 1993-11-09 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
EP1062954B1 (en) * 1998-10-27 2007-05-30 Suntory Limited Use of itaconic acid for regulation of glycolytic metabolism
EP2480531B1 (en) * 2009-09-21 2014-11-05 ChemoCentryx, Inc. Pyrrolidinone carboxamide derivatives as chemerin-r (chemr23) modulators
LU91877B1 (en) * 2011-09-23 2013-03-25 Univ Luxembourg Method to predict the presence of itaconic Acid, IRG1 and/or protein IRG1 in a subject and pharmaceutical composition for performing gene therapy
US8691993B2 (en) * 2011-12-12 2014-04-08 Hoffmann-La Roche Inc. Piperidinyl naphthylacetic acids
JP2015516965A (ja) * 2012-04-03 2015-06-18 アポセンス リミテッドAposense Ltd. 診断指標及び治療指標のための新規な標的指向性薬剤
EP3416634A4 (en) * 2016-02-15 2019-10-09 Artyomov, Maxim IMMUNOMODULATORY AGENTS AND METHOD FOR USE THEREOF

Also Published As

Publication number Publication date
JP2021529752A (ja) 2021-11-04
EP3813815A1 (en) 2021-05-05
JP7396682B2 (ja) 2023-12-12
EP3813815C0 (en) 2026-01-28
EP3813815A4 (en) 2022-04-20
US20210261495A1 (en) 2021-08-26
EP3813815B1 (en) 2026-01-28
US12060310B2 (en) 2024-08-13
WO2020006557A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
ZA201707981B (en) Compositions of obeticholic acid and methods of use
ZA201906169B (en) Synthekine compositions and methods of use
SG11201707683YA (en) C/ebp alpha sarna compositions and methods of use
SG11202105730TA (en) Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
IL276135A (en) Preparations and methods of use
IL274635A (en) Stable ascorbic acid preparations and methods of using them
ZA202100780B (en) Bismuth-thiol compositions and methods of use
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
EP3288379A4 (en) Peptide compositions and methods of use
ES3063485T3 (en) Compositions and methods of using itaconic acid derivatives
SG11201803284YA (en) Novel method of use and compositions
IL274563A (en) Methods of use and preparations containing dolaglutide
GB2561121B (en) Branched acid emulsifier compositions and methods of use
PL3867446T3 (pl) Kompozycje kleju do cylindra typu yankee i sposoby użycia tych kompozycji
IL273690A (en) Gingivitis vaccine and related preparations and methods of using it
IL273850A (en) Preparations and methods for the treatment of leprosy
EP3253396A4 (en) Probiotic compositions and methods of use
EP3504267B8 (en) Oligoesters compositions and methods of making and using same
EP3256094A4 (en) Dental compositions and methods of use
EP3313399A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING RIT1
GB201919385D0 (en) Compositions and methods of manufacture
HK40036149A (en) Cas12c compositions and methods of use
HK40036150A (en) Casz compositions and methods of use